ClinOne

Executive Summary

ClinOne, a Denver-based digital health company, has developed a unified platform designed to connect, inform, and empower clinical trial participants, care partners, and trial sites. By integrating patient-facing and site-facing functionalities into a single system, ClinOne simplifies and enhances the clinical trial experience, improving engagement and operational efficiency. The company was acquired by uMotif, a strategic consolidation in the clinical trial technology sector, signaling an intent to create a more comprehensive solution for the life sciences industry. Despite the acquisition, ClinOne’s platform continues to serve as a key component within uMotif’s broader offering, focusing on patient-centric digital health tools that streamline trial workflows and data collection. The combined entity is well-positioned to capitalize on the growing demand for decentralized and hybrid trial technologies, though specific financial details remain private.

Upcoming Catalysts (preview)

• Q3 2026Integration with uMotif Platform80% success
• Q4 2026New Contract Wins for Unified Clinical Trial Solution60% success
• Q1 2027Expansion into Phase I and Real-World Evidence Studies50% success